David L. Roman

2.0k total citations
55 papers, 1.2k citations indexed

About

David L. Roman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, David L. Roman has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 12 papers in Cellular and Molecular Neuroscience and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in David L. Roman's work include Receptor Mechanisms and Signaling (28 papers), Protein Kinase Regulation and GTPase Signaling (26 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). David L. Roman is often cited by papers focused on Receptor Mechanisms and Signaling (28 papers), Protein Kinase Regulation and GTPase Signaling (26 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). David L. Roman collaborates with scholars based in United States, Switzerland and France. David L. Roman's co-authors include Richard R. Neubig, John R. Traynor, Michael P. Hayes, Levi L. Blazer, Rebecca A. Roof, Roger K. Sunahara, Jeffery N. Talbot, Christopher Bodle, Bernhard Ryffel and M. J. Mihatsch and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Chemistry.

In The Last Decade

David L. Roman

54 papers receiving 1.2k citations

Peers

David L. Roman

CMN

IMMUN

ONCOL

RHEUM

Katherine Lansu United States

Iris Grossman Israel

Yan Xia China

Mary Kathryn Doud United States

Andreas Langer Germany

Bianca Plouffe Canada

Hirokazu Tsujimoto Japan

Michael J. Karmilowicz United States

Chiara Parravicini Italy

Tomomi Kiyota United States

Katherine Lansu United States

David L. Roman

718 ×0.9

390 ×1.6

CMN

196 ×1.5

IMMUN

69 ×0.9

ONCOL

49 ×0.6

RHEUM

Citations per year, relative to David L. Roman David L. Roman (= 1×) peers Katherine Lansu

Countries citing papers authored by David L. Roman

Since Specialization

Citations

This map shows the geographic impact of David L. Roman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Roman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Roman more than expected).

Fields of papers citing papers by David L. Roman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Roman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Roman. The network helps show where David L. Roman may publish in the future.

Co-authorship network of co-authors of David L. Roman

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Roman. A scholar is included among the top collaborators of David L. Roman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Roman. David L. Roman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lehmler, Hans‐Joachim, et al.. (2024). High-Throughput GPCRome Screen of Pollutants Reveals the Activity of Polychlorinated Biphenyls at Melatonin and Sphingosine-1-phosphate Receptors. Chemical Research in Toxicology. 37(2). 439–449. 3 indexed citations

Ptak, Christopher P., et al.. (2022). Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotype. Frontiers in Pharmacology. 13. 977742–977742. 3 indexed citations

Dujardin, Kathy, David L. Roman, Guillaume Baille, et al.. (2019). What can we learn from fMRI capture of visual hallucinations in Parkinson’s disease?. Brain Imaging and Behavior. 14(2). 329–335. 20 indexed citations

Bodle, Christopher, et al.. (2018). Screen Targeting Lung and Prostate Cancer Oncogene Identifies Novel Inhibitors of RGS17 and Problematic Chemical Substructures. SLAS DISCOVERY. 23(4). 363–374. 3 indexed citations

Hayes, Michael P. & David L. Roman. (2016). Regulator of G Protein Signaling 17 as a Negative Modulator of GPCR Signaling in Multiple Human Cancers. The AAPS Journal. 18(3). 550–559. 14 indexed citations

Brust, Tarsis F., Michael P. Hayes, David L. Roman, Kevin D. Burris, & Val J. Watts. (2014). Bias Analyses of Preclinical and Clinical D2 Dopamine Ligands: Studies with Immediate and Complex Signaling Pathways. Journal of Pharmacology and Experimental Therapeutics. 352(3). 480–493. 32 indexed citations

Hagen, Jussara, Gary S. Coombs, Christine M. Eischen, et al.. (2013). RABL6A, a Novel RAB-Like Protein, Controls Centrosome Amplification and Chromosome Instability in Primary Fibroblasts. PLoS ONE. 8(11). e80228–e80228. 10 indexed citations

Roman, David L., et al.. (2013). A High Throughput Screen for RGS Proteins Using Steady State Monitoring of Free Phosphate Formation. PLoS ONE. 8(4). e62247–e62247. 25 indexed citations

Higgins, Colin, et al.. (2012). Expression and purification of recombinant human tyrosine hydroxylase as a fusion protein in Escherichia coli. Protein Expression and Purification. 84(2). 219–223. 7 indexed citations

10.

Roman, David L., et al.. (2011). Development of a Novel High-Throughput Screen and Identification of Small-Molecule Inhibitors of the Gα–RGS17 Protein–Protein Interaction Using AlphaScreen. SLAS DISCOVERY. 16(8). 869–877. 16 indexed citations

11.

Blazer, Levi L., David L. Roman, Alfred Chung, et al.. (2010). Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins. Molecular Pharmacology. 78(3). 524–533. 70 indexed citations

12.

Roman, David L., et al.. (2010). Allosteric Inhibition of the Regulator of G Protein Signaling–Gα Protein–Protein Interaction by CCG-4986. Molecular Pharmacology. 78(3). 360–365. 38 indexed citations

13.

Roman, David L., et al.. (2009). Polyplexed Flow Cytometry Protein Interaction Assay: A Novel High-Throughput Screening Paradigm for RGS Protein Inhibitors. SLAS DISCOVERY. 14(6). 610–619. 35 indexed citations

14.

Roman, David L., et al.. (2008). In vitro protein kinase activity measurement by flow cytometry. Analytical Biochemistry. 383(2). 180–185. 8 indexed citations

15.

Roman, David L., Jeffery N. Talbot, Rebecca A. Roof, et al.. (2006). Identification of Small-Molecule Inhibitors of RGS4 Using a High-Throughput Flow Cytometry Protein Interaction Assay. Molecular Pharmacology. 71(1). 169–175. 116 indexed citations

16.

Roman, David L., Shannon N. Saldaña, David E. Nichols, F. Ivy Carroll, & Eric L. Barker. (2004). Distinct Molecular Recognition of Psychostimulants by Human and Drosophila Serotonin Transporters. Journal of Pharmacology and Experimental Therapeutics. 308(2). 679–687. 8 indexed citations

17.

Roman, David L., et al.. (2003). Interactions of antidepressants with the serotonin transporter: a contemporary molecular analysis. European Journal of Pharmacology. 479(1-3). 53–63. 41 indexed citations

18.

Rodríguez, Gustavo, David L. Roman, Kate White, David E. Nichols, & E L Barker. (2003). Distinct Recognition of Substrates by the Human and Drosophila Serotonin Transporters. Journal of Pharmacology and Experimental Therapeutics. 306(1). 338–346. 17 indexed citations

19.

Ozmen, Laurence, et al.. (1994). Soluble Interferon-γ Receptor: A Therapeutically Useful Drug for Systemic Lupus Erythematosus. Journal of Interferon Research. 14(5). 283–284. 7 indexed citations

20.

Ryffel, Bernhard, et al.. (1994). Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.. PubMed. 144(5). 927–37. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact